HANNAH DAVIDSON: Open Payments
NPI 1467005199 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 35 payments from 16 companies in 2025. Trend: 2023 $663 · 2024 $337 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $215 |
| PFIZER INC. | 4 | $76 |
| Astellas Pharma US Inc | 4 | $73 |
| Geron Corporation | 2 | $66 |
| Incyte Corporation | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $43 |
| SOBI, INC | 1 | $26 |
| KYOWA KIRIN, INC. | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Syndax Pharmaceuticals, Inc. | 1 | $22 |
Products named: IMBRUVICA, EPKINLY, RYTELO, Xospata, VENCLEXTA, ELREXFIO, Vanflyta, Vonjo.
Industry payments across CO — which companies pay providers there.
